Pharmafile Logo
Pharmafocus logo
Advanced Search

Setback on road to recovery for Genzyme’s Allston facility

March 28, 2011
Manufacturing and Production Genzyme

Genzyme has been forced to discard one lot of its Fabry disease treatment Fabrazyme (agalsidase beta) manufactured at its troubled …

News

Kantar Health Names Jim Needell Managing Director, UK

March 28, 2011

Kantar Health Names Jim Needell Managing Director, UKNEW YORK, March 28, 2011—Kantar Health, a leading healthcare-focused global consultancy and marketing …

News
Press release

Nycomed files short bowel syndrome treatment

March 28, 2011
Medical Communications Nycomed, Revestive, gastrointestinal

Specialist pharma company Nycomed has submitted a novel bowel disease treatment for assessment by European regulators. The Marketing Authorisation Application …

News

New melanoma drug approved by FDA

March 28, 2011
Sales and Marketing BMS, melanoma

Yervoy, Bristol Myers Squibb’s new treatment for advanced skin cancer has gained approval in the US. The drug is the …

News
Pfizer Real Danger medicine spam

Digital Pharma: Social media boost for Pfizer anti-counterfeits campaign

March 28, 2011
Medical Communications Digital Pharma blog, Pfizer, counterfeits

Pfizer UK is using social media to reinvigorate its Real Danger patient safety campaign. The next phase of the campaign, …

News

Telaprevir to be added to standard hep C therapy

March 27, 2011
Research and Development, Sales and Marketing hepatitis C, telaprevir

Telaprevir – currently being co-developed by Vertex, Johnson & Johnson and Mitsubishi Tanabe  – will become part of a standard …

News

GSK withdraws applications for Avodart

March 25, 2011
Research and Development Avodart, Cancer, GSK, bph, prostate cancer

GlaxoSmithKline has withdrawn all regulatory applications for Avodart to prevent prostate cancer after regulators raised doubts about its benefit/risk profile. …

News
Novartis Diagnostics Filiberto de Cal

Working Life: Novartis’ Filiberto de Cal

March 25, 2011
Business Services, Sales and Marketing Novartis, Working Life, recruitment

Filiberto de Cal is director of global marketing – new products at Novartis Diagnostics. Here he outlines his route into …

News

Merck drops oral anticoagulant

March 25, 2011
Merck, Pradaxa, Xarelto, anticoagulant, atrial fibrilation, vorapaxar

Merck has given the rights to its oral anticoagulant betrixaban back to Portola Pharmaceuticals after a review of its late …

News
Sanofi-Aventis headquarters

Sanofi signs ophthalmology research collaboration

March 25, 2011
Research and Development Fovea, Sanofi-Aventis, Vision Institute, ophthalmology

Sanofi-Aventis has penned a collaboration with one of the main eye disease research centres in Europe. The three-year agreement between …

News

Cephalon buys Gemin X for $225 million

March 24, 2011
Research and Development Cephalon, lung cancer

Cephalon is to acquire oncology specialist Gemin X and gain access to its cancer candidate obatoclax. The US biopharmaceutical firm …

News
aquapharm_bertrand_lehuu

Bertrand Lehuu joins Aquapharm

March 24, 2011
Research and Development appointment, research and development

Scottish marine biotechnology company Aquapharm Biodiscovery has appointed Bertrand Lehuu as senior VP – pharma business. Bertrand has almost 30 …

Appointment

The Real-Time Rep Becomes a Reality – Changing the Rules of Engagement with Customers

March 24, 2011
Sales and Marketing

The Real-Time Rep Defined The Real-Time Rep, no longer a fictitious ideal, is a salesperson who is able to:

Feature
Thought Leadership

Budget provides UK science incentives

March 24, 2011
Research and Development George Osborne, R&D tax credits, clinical trials

Chancellor George Osborne has unveiled tax incentives, new funding and moves to cut red tape for the life sciences sector …

News
Pharma on Facebook

Digital Pharma: European pharma and social media

March 24, 2011
Medical Communications, Sales and Marketing Digital Pharma blog, Facebook, Twitter, social media, youtube

European pharma is increasingly running local social media initiatives as companies expand on their first, centrally-driven, uses of the technology.Details …

Feature

FDA delays decision on Novartis’ COPD drug

March 23, 2011
Sales and Marketing COPD, Novartis, Onbrez Breezhaler, QAB149, bronchodilator, chronic obstructive pulmonary disease, indacterol

The FDA has delayed its licence decision on Novartis’ once-daily COPD treatment QAB149 by three months. The review process will …

News

Eisai marine sponge derived cancer drug approved in Europe

March 23, 2011
Sales and Marketing Cancer, Eisai, Halaven, Halichondria okadai, breast cancer, eribulin mesylate

Eisai’s injectible breast cancer drug Halaven has been approved by European regulators. The highly novel drug is made from a …

News

Kantar Health Names Andrew Miniuks Senior Director, Oncology Market Access

March 23, 2011

Kantar Health Names Andrew Miniuks Senior Director, Oncology Market AccessNEW YORK, March 22, 2011—Kantar Health, a leading healthcare-focused global consultancy …

News
Press release
GlaxoSmithKline office

GSK to fund schools science programme

March 23, 2011
Research and Development, Sales and Marketing GSK, GlaxoSmithKline, King's College, school science

GlaxoSmithKline has followed its pledge to refund the tuition fees of UK graduates it takes on with a less direct …

News

Publicis buys Indian health advertising agency

March 23, 2011
Medical Communications Publicis Groupe, Publicis Life Brands Watermelon, Watermelon Healthcare Communications, healthcare communications agency, publicis

Publicis Groupe is to acquire a majority stake in a leading Indian healthcare advertising agency, Mumbai-based Watermelon Healthcare Communications. Publicis …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026